Local 12: Report: Person was 'cured' of HIV, but a local doctor says treatment is dangerous
UC expert has concerns about stem cell transplants
New research published in the Nature Medicine journal says a 53-year-old German man is now clear of HIV after a procedure that replaced his bone marrow cells with HIV-resistant stem cells from a donor. He is just the third person to be cured of HIV.
WKRC-TV, Local 12, interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the University of Cincinnati College of Medicine, who was at the scientific meeting in Seattle where this research was released.
"I do hope in my professional lifetime will be able to see him the situation where we can cure a disease like HIV,” said Fichtenbaum. "Every year, we get a little bit closer to a better answer.”
/content/dam/uc/news/ahc-public-relations/medicine/fichtenbaum-lab-folder.jpg/Photo/Colleen Kelley/UC Marketing + Brand
While the news about the German patient is exciting, Fichtenbaum knows it doesn't do much for the average person living with the virus.
"It’s very important, it gives us hope, but it’s not a scalable cure that can be down at your local pharmacy tomorrow," said Fichtenbaum.
That is mostly because of how specific the patient's health condition is and because Fichtenbaum says operations like stem cell transplants are extremely dangerous.
"We have tried this several times and it’s failed because bone marrow transplant transplants, stem cell transplants are dangerous, and these are mostly used in individuals who have cancer,” said Fichtenbaum.
Lead photo/Aaron Ufumeli/EPA-EFE
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.